12:00 AM
 | 
Sep 20, 1999
 |  BC Week In Review  |  Company News  |  Deals

Advanced Tissue, Inamed deal

IMDC exercised its option under the partners' May agreement, acquiring an exclusive worldwide license to ATIS's human collagen for use in wrinkle and...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >